APA (7th ed.) Citation

M, K., H, H., M, K., Y, T., K, S., A, D., . . . T, T. (2024). Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study. PloS one, 19(1), e0294590. https://doi.org/10.1371/journal.pone.0294590

Chicago Style (17th ed.) Citation

M, Kai, et al. "Clinical Factors Associated with the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: A Multicenter Prospective Observational Study." PloS One 19, no. 1 (2024): e0294590. https://doi.org/10.1371/journal.pone.0294590.

MLA (9th ed.) Citation

M, Kai, et al. "Clinical Factors Associated with the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: A Multicenter Prospective Observational Study." PloS One, vol. 19, no. 1, 2024, p. e0294590, https://doi.org/10.1371/journal.pone.0294590.